Detection of enterovirus genome in cerebrospinal fluid by gene amplification in meningitis patients - INAHTA Brief

According to professionals in the field, detection of enterovirus (EV) genome in cerebrospinal fluid (CSF) by gene amplification has been gradually becoming standard practice in the management of meningitis over the past 10 or so years, especially since ready-to-use kits came onto the market

With a view to having this diagnostic test reimbursed by National Health Insurance, CNAMTS [National Salaried Workers’ Health Insurance Fund] and the French Society for Microbiology agreed on a joint request to the Haute Autorité de Santé for an assessment of this diagnostic tool

The purpose of this assessment is to make sure that enterovirus genome detection in CSF by gene amplification is a validated diagnostic tool in the management of meningitis cases